Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV
Mihkel Örd, Ilona Faustova, Mart Loog
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 157

Showing 1-25 of 157 citing articles:

COVID-19 and SARS-CoV-2. Modeling the present, looking at the future
Ernesto Estrada
Physics Reports (2020) Vol. 869, pp. 1-51
Open Access | Times Cited: 206
SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids
Jitske Jansen, Katharina C. Reimer, James S. Nagai, et al.
Cell stem cell (2021) Vol. 29, Iss. 2, pp. 217-231.e8
Open Access | Times Cited: 198
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
Alba Escalera, Ana S. González-Reiche, Sadaf Aslam, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 373-387.e7
Open Access | Times Cited: 174
Overview of SARS-CoV-2 genome-encoded proteins
Chongzhi Bai, Qiming Zhong, George F. Gao
Science China Life Sciences (2021) Vol. 65, Iss. 2, pp. 280-294
Open Access | Times Cited: 153
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 992-992
Open Access | Times Cited: 134
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 130
SARS-CoV-2 and the Host Cell: A Tale of Interactions
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, et al.
Frontiers in Virology (2022) Vol. 1
Open Access | Times Cited: 69
The role of cell surface sialic acids for SARS-CoV-2 infection
Xue‐Long Sun
Glycobiology (2021) Vol. 31, Iss. 10, pp. 1245-1253
Open Access | Times Cited: 96
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Javier T. Granados‐Riveron, Guillermo Aquino‐Jarquín
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111953-111953
Open Access | Times Cited: 95
Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 384-398
Open Access | Times Cited: 75
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 42
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
Subhomoi Borkotoky, Debajit Dey, Zaved Hazarika
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2713-2721
Open Access | Times Cited: 37
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Zhuocheng Yao, Lin Zhang, Yuange Duan, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106121-106121
Open Access | Times Cited: 14
Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination
Md. Golzar Hossain, Yan‐Dong Tang, Sharmin Akter, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 5, pp. 1815-1820
Closed Access | Times Cited: 48
Severity, Pathogenicity and Transmissibility of Delta and Lambda Variants of SARS-CoV-2, Toxicity of Spike Protein and Possibilities for Future Prevention of COVID-19
Mehrnoosh Moghaddar, Ramtin Radman, Ian Macreadie
Microorganisms (2021) Vol. 9, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 43
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System
Giselle Pentón‐Rol, Javier Marín‐Prida, Mark F. McCarty
Current Neuropharmacology (2021) Vol. 19, Iss. 12, pp. 2250-2275
Open Access | Times Cited: 41
Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco
James Peng, Jamin Liu, Sabrina A Mann, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 1, pp. 32-39
Open Access | Times Cited: 41
Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19
Shibi Muralidar, Gayathri Gopal, Senthil Visaga Ambi
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5260-5276
Open Access | Times Cited: 40
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Ritika Khatri, Gazala Siddqui, Srikanth Sadhu, et al.
Medical Microbiology and Immunology (2022) Vol. 212, Iss. 1, pp. 103-122
Open Access | Times Cited: 35
Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy
Harry Ridgway, Christos T. Chasapis, Konstantinos Kelaidonis, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 33
SARS‐CoV‐2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion
Federica Quaglia, Edoardo Salladini, Marco Carraro, et al.
FEBS Journal (2022) Vol. 289, Iss. 14, pp. 4240-4250
Open Access | Times Cited: 30
Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern
Sylwia D. Tyrkalska, Alicia Martínez‐López, Ana B. Arroyo, et al.
Science Advances (2022) Vol. 8, Iss. 37
Open Access | Times Cited: 28
Host range, transmissibility and antigenicity of a pangolin coronavirus
Yixuan J. Hou, S. Chiba, Sarah R. Leist, et al.
Nature Microbiology (2023) Vol. 8, Iss. 10, pp. 1820-1833
Open Access | Times Cited: 21
O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern
Edgar González-Rodríguez, Mia Zol-Hanlon, Ganka Bineva‐Todd, et al.
ACS Central Science (2023) Vol. 9, Iss. 3, pp. 393-404
Open Access | Times Cited: 19
COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top